Hawaii pharma company enters exclusive agreement with GNC to sell dietary supplement

Honolulu-based pharmaceutical company Cardax Inc. (OTCQB:CDXI) on Friday said it entered into a mutual exclusivity agreement with General Nutrition Corp. (NYSE: GNC) for its dietary supplement ZanthoSyn. The agreement follows the company’s recently announced national rollout of ZanthoSyn across GNC’s more than 3,200 U.S. stores and designates GNC as the exclusive national “brick-and-mortar” retailer of ZanthoSyn. The agreement between GNC and ZanthoSyn will initially run for two years and …
Source: bizjournals.com Health Care:Physician Practices headlines - Category: American Health Authors: Source Type: news